SARV-CoV-2 infection was considered pandemic on March 11, 2020. The SARV-CoV-2 epidemic affected France from the beginning of March, spreading in particular from a 4-day large evangelical meeting of 2500 people on February 17 in the city of Mulhouse (North East of France). The Montpellier University Hospital has set up a clinical pathway for people suspected of being infected with SARV-CoV-2 because of signs compatible with pneumonia (screening criteria in France during the study period). This includes an emergency department, an infectious disease department dedicated to the surveillance of infected people requiring hospital treatment, and an intensive care unit for the most severe cases. The diagnosis of infection with SARV-CoV-2 was confirmed in approximately 20% of people initially referred in this special care system. The main objective of this cohorte is the collection of clinical data and biological samples from care for non-interventional research on the patients with a possible or confirmed SARS-CoV -2 infection, from diagnosis to long-term follow-up.
Study Type
OBSERVATIONAL
Enrollment
500
Collection
Uh Montpellier
Montpellier, France
RECRUITINGNumber of confirmed COVID-19
Number of confirmed COVID-19
Time frame: 1 day
Number of severe COVID-19
Number of severe COVID-19
Time frame: 1 day
Identification and validation of predictive biomarkers of a poorer respiratory evolution associated with positive testing for SARS-CoV-2 infection
CORO-TRI substudy
Time frame: 1 day
Evaluate the morbidity and mortality and these risk factors linked to Covid-19 in the congenital heart disease population in France
COVID-CHD substudy
Time frame: 1 day
Identify the characteristics of physiotherapy care for patients with COVID-19 in intensive care
Physio-Covid substudy
Time frame: 1 day
To assess the accuracy and prognostic performance of clinical and biological parameters measured on admission to the emergency department to stratify patients suspected of COVID-19
Covida substudy
Time frame: 1 day
Evaluate diagnostic tests for olfactory function in relation to the RT-PCR procedure
Olfa-covid substudy
Time frame: 1 day
Assessment of Extra Vascular Lung Water and Pulmonary Permeability by transpulmonary thermodilution in critically ill patients with Coronavirus Disease 2019 pneumonia under invasive mechanical ventilation
PiCCOVID substudy
Time frame: 1 day
Description of trans pulmonary motor pressure in COVID 19+ patients in severe stage in intensive care
TRANSPULMONARY-COVID19 substudy
Time frame: 1 day
Immuno-monitoring of COVID-19 positive patients
CytoCOVID substudy
Time frame: 1 day
Characterization in clinical proteomics of the SARS-CoV-2 spike protein
ProteoCOVID substudy
Time frame: 1 day
Diagnosis of endocrine dysfunctions in Covid-19
Dyhor-19 substudy
Time frame: 1 day
describe the occurrence of Covid19 infection in patients with systemic lupus erythematosus treated with hydroxychloroquine over the long term
Lupus substudy
Time frame: 1 day
Acral cutaneous thrombotic vasculopathy and Covid-19 infection : search for acquired thrombophilia and interferon-alpha signature
Vasculopathy substudy
Time frame: 1 day
Evaluation of a COVID-19 screening strategy combining chest low dose CT and RT-PCR test for patients admitted for surgical or interventional procedures during the COVID 19 outbreak
COVID-Scan study
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.